Skip to main content

Table 9 Literature comparison of survivorship between treatment options for younger patients

From: Metal-on-metal hip resurfacing in patients younger than 50 years: a retrospective analysis

Study

Procedure

Prosthesis

Date range

Diagnosis (years)

Patient cohort

Avg FU (years)

Survivorship

Hips

Female (%)

FU

Rate (%)

Jameson et al. [51]

HRA

Birmingham

2004–2007

<55

254

39

2.3

3.8

97

Matharu et al. [45]

HRA

Birmingham

1997–2006

<50

447

28

10.1

10

96

Woon et al. [52]

HRA

Conserve Plus

1996–2010

<30

53

39

8.2

8

95

Amstutz et al. [53]

HRA

Conserve Plus

1998–2007

<50

350

25

5.5

5

97.8

Krantz et al. [44]

HRA

Conserve Plus and Durom

2007–2008

<30

24

32

4.2

4.9

100

Haddad et al. [23]

HRA

Birmingham

1999–2002

<55

40

25

12

10

100

Matharu et al. [54]

HRA

Conserve Plus and Corin Cormet 2000

2001–2007

<25 + osteonecrosis

20

50

5.2

8.6

100

Matharu et al. [54]

THA

Stryker Accolade II stem and Trident cup

2001–2007

<25 + osteonecrosis

20

38

5.2

7.3

93

Wroblewski et al. [55]

THA

Charnley

1962–1990

<51

1434

61

15

17

83

Current study

HRA

Corin Surface and Biomet ReCap™

2008–2013

<50

1285

26

3.4

12

96